| 101 |
28131132 | Fibroblast Growth Factor 23-Mediated Bone Disease. | 2017 Mar |
2 |
| 102 |
28497083 | Impact of FGF23 level on calcium and phosphorus levels in post-renal transplantation. | 2017 |
2 |
| 103 |
28615947 | Treatment of secondary hyperparathyroidism: the clinical utility of etelcalcetide. | 2017 |
2 |
| 104 |
28860784 | Effect of additive calcium administration on FGF23 levels in patients with mild chronic kidney disease treated with calcitriol: a randomized, open-labeled clinical trial. | 2017 |
1 |
| 105 |
29096595 | Pleiotropic Actions of FGF23. | 2017 Oct |
2 |
| 106 |
29179169 | [Bone remodeling through a phosphate metabolism.] | 2017 |
1 |
| 107 |
26069294 | Normal 25-Hydroxyvitamin D Levels Are Associated with Less Proteinuria and Attenuate Renal Failure Progression in Children with CKD. | 2016 Jan |
2 |
| 108 |
26287968 | Xeno-Klotho Inhibits Parathyroid Hormone Signaling. | 2016 Feb |
1 |
| 109 |
26307135 | Fibroblast growth factor 23: associations with antiretroviral therapy in patients co-infected with HIV and hepatitis C. | 2016 May |
1 |
| 110 |
26476373 | FGF23-regulated production of Fetuin-A (AHSG) in osteocytes. | 2016 Feb |
1 |
| 111 |
26567701 | Therapeutic potential of the endocrine fibroblast growth factors FGF19, FGF21 and FGF23. | 2016 Jan |
1 |
| 112 |
26620085 | FGF23-S129F mutant bypasses ER/Golgi to the circulation of hyperphosphatemic familial tumoral calcinosis patients. | 2016 Dec |
1 |
| 113 |
26784540 | Pruning the ricket thicket. | 2016 Feb |
1 |
| 114 |
26813507 | [FGF23 related hypophosphatemic rickets:current therapy and unresolved issues]. | 2016 Feb |
1 |
| 115 |
26864938 | FGF23 from bench to bedside. | 2016 Jun 1 |
1 |
| 116 |
26928188 | Stability and degradation of fibroblast growth factor 23 (FGF23): the effect of time and temperature and assay type. | 2016 Jul |
2 |
| 117 |
26939683 | Fibroblast growth factor-23 and renin-angiotensin system levels in vitamin-D-dependent rickets type I. | 2016 Jul |
1 |
| 118 |
26943611 | The FGF23/Klotho axis in the regulation of mineral and metabolic homeostasis. | 2016 Oct 1 |
2 |
| 119 |
26943634 | Fibroblast Growth Factor 23 Concentrations Reflect Sex Differences in Mineral Metabolism and Growth in Early Infancy. | 2016 |
1 |
| 120 |
27012053 | The Superiority of AN69ST Membrane in the Adsorption of Fibroblast Growth Factor-23. | 2016 |
1 |
| 121 |
27125741 | The FGF23/KLOTHO Regulatory Network and Its Roles in Human Disorders. | 2016 |
2 |
| 122 |
27134818 | Systemic Control of Bone Homeostasis by FGF23 Signaling. | 2016 Mar 1 |
2 |
| 123 |
27178987 | Update on FGF23 and Klotho signaling. | 2016 Sep 5 |
2 |
| 124 |
27191351 | Inflammation regulates fibroblast growth factor 23 production. | 2016 Jul |
2 |
| 125 |
27215149 | Fibroblast growth factor 23 in acute burn patients: Novel insights from an intact-form assay. | 2016 Aug |
2 |
| 126 |
27215557 | Klotho, the Holy Grail of the kidney: from salt sensitivity to chronic kidney disease. | 2016 Oct |
1 |
| 127 |
27219044 | Multiple faces of fibroblast growth factor-23. | 2016 Jul |
3 |
| 128 |
27355663 | Development and Validation of a Simple Diagnostic Method to Detect Gain and Loss of Function Defects in Fibroblast Growth Factor-23. | 2016 |
2 |
| 129 |
27403909 | [Fibroblast growth factor 23 in chronic kidney disease in children]. | 2016 Jun |
1 |
| 130 |
27495287 | Effect of oral sodium bicarbonate on fibroblast growth factor-23 in patients with chronic kidney disease: a pilot study. | 2016 Aug 5 |
1 |
| 131 |
27652999 | FGF-23 and cardiovascular disease: review of literature. | 2016 Dec |
1 |
| 132 |
27721584 | The Three Sisters of Fate in Multiple Sclerosis: Klotho (Clotho), Fibroblast Growth Factor-23 (Lachesis), and Vitamin D (Atropos). | 2016 Sep |
2 |
| 133 |
27812184 | Vitamin D, Fibroblast Growth Factor 23 and Incident Cognitive Impairment: Findings from the REGARDS Study. | 2016 |
2 |
| 134 |
27941640 | Fibroblast Growth Factor-23-A Potential Uremic Toxin. | 2016 Dec 8 |
1 |
| 135 |
24620922 | The fibroblast growth factor-23 and Vitamin D emerge as nontraditional risk factors and may affect cardiovascular risk. | 2015 Mar |
1 |
| 136 |
25168424 | The role of bone in CKD-mediated mineral and vascular disease. | 2015 Sep |
1 |
| 137 |
25270396 | Increased serum fibroblast growth factor-23 and decreased bone turnover in patients with systemic lupus erythematosus under treatment with cyclosporine and steroid but not steroid only. | 2015 Feb |
1 |
| 138 |
25366373 | Associations between the levels of sclerostin, phosphate, and fibroblast growth factor-23 and treatment with vitamin D in hemodialysis patients with low intact PTH level. | 2015 Mar |
1 |
| 139 |
25451947 | Serum free 1,25-dihydroxy-vitamin D is more closely associated with fibroblast growth factor 23 than other vitamin D forms in chronic dialysis patients. | 2015 Jan 15 |
4 |
| 140 |
25470522 | Bone tissue as a systemic endocrine regulator. | 2015 |
1 |
| 141 |
25530521 | [Bone and Calcium Research Update 2015. Novel treatment for FGF23-related hypophosphatemic diseases]. | 2015 Jan |
3 |
| 142 |
25563643 | Fibroblast growth factor 23 and risk of incident stroke in community-living adults. | 2015 Feb |
2 |
| 143 |
25597001 | [Native vitamin D in dialysis patients]. | 2015 Feb |
1 |
| 144 |
25637898 | [Oncogenic osteomalacia. Report of two cases]. | 2015 |
1 |
| 145 |
25716806 | [Current Topics on Vitamin D. Cross talks among vitamin D endocrine system, PTH and FGF23]. | 2015 Mar |
1 |
| 146 |
25873267 | Effect of Cinacalcet and Vitamin D Analogs on Fibroblast Growth Factor-23 during the Treatment of Secondary Hyperparathyroidism. | 2015 Jun 5 |
6 |
| 147 |
25934099 | Angiotensin II blockade: how its molecular targets may signal to mitochondria and slow aging. Coincidences with calorie restriction and mTOR inhibition. | 2015 Jul 1 |
2 |
| 148 |
26019137 | FGF23 promotes prostate cancer progression. | 2015 Jul 10 |
2 |
| 149 |
26023015 | Klotho/FGF23 Axis in CKD. | 2015 |
1 |
| 150 |
26066475 | Epidemiologic insights on the role of fibroblast growth factor 23 in cardiovascular disease. | 2015 May |
2 |